Skip to content

阿尔法科技骨科

US · ATEC #2945 按市值排名 上市于 1970
10.46 -0.47 -4.30%
实时 - 追踪5344个代码 - 心跳于563秒前 · 2026-10-16 19:30

✦ 量化财务健康度 计算方式说明

偏弱
  • 奥特曼 Z 值为-0.20,低于1.8的"危险区"阈值。
  • 该模型对工业和制造业公司最为可靠,对银行、保险等金融类公司参考意义较弱。

营收 年度数据,近8年

最近年度同比+24.95%

利润率

毛利率
69.60%
营业利润率
-7.59%
净利率
-18.76%

关键比率与质量指标

奥特曼 Z 值低于约1.8提示财务困境风险,高于约3.0提示风险较低;该模型对工业和制造业公司最为可靠,对银行等金融类公司参考意义较弱。

利润表

项目 2018 2019 2020 2021 2022 2023 2024 2025
营收 91.69M113.43M144.86M243.21M350.87M482.26M611.56M764.16M
毛利润 63.24M77.59M102.50M157.76M233.06M310.20M424.26M531.89M
销售及管理费用 72.64M101.71M129.16M229.27M300.01M374.08M450.20M498.53M
研发费用 9.85M13.85M18.75M32.02M44.03M70.12M80.72M76.27M
营业利润 -19.99M-38.67M-46.09M-108.87M-121.10M-148.28M-122.91M-57.97M
税前利润 -30.17M-57.14M-78.85M-144.16M-152.01M-186.92M-162.07M-143.40M
税费 -1.36M-239.00K145.00K-1.13M-716.00K-277.00K50.00K-45.00K
净利润 -28.98M-57.00M-78.99M-143.03M-151.29M-186.64M-162.12M-143.36M
基本每股收益 -1-1-1-1-1-2-1-1
稀释每股收益 -1.20-1.09-1.18-1.49-1.46-1.54-1.13-0.96

资产负债表

项目 2018 2019 2020 2021 2022 2023 2024 2025
流动资产总额 75.54M108.32M184.16M331.16M255.63M451.09M417.40M450.88M
现金及短期投资 29.05M47.11M107.77M187.25M84.70M220.97M138.84M160.81M
存货 28.77M34.85M46.00M91.70M101.52M136.84M175.26M169.44M
总资产 129.48M169.95M261.22M572.05M520.97M805.21M775.71M791.21M
流动负债总额 30.61M36.39M58.31M101.10M138.87M157.57M153.03M219.18M
短期负债 3.28M1.80M5.05M4.55M19.79M6.97M8.11M70.82M
长期负债 42.30M53.45M38.00M326.49M349.51M511.04M574.52M501.41M
总负债 111,903,000.00126,317,000.00131,343,000.00492,631,000.00555,635,000.00727,092,000.00789,879,000.00778,782,000.00
股东权益总额 17.57M43.63M129.88M79.42M-34.67M78.12M-14.17M12.43M
留存收益 -501.92M-558.92M-638.00M-782.33M-932.32M-1.12B-1.28B-1.42B

现金流量表

项目 2018 2019 2020 2021 2022 2023 2024 2025
经营活动现金流 -25.61M-33.12M-46.41M-73.32M-75.13M-78.49M-44.65M45.23M
折旧与摊销 6.79M8.51M11.63M30.17M43.93M59.68M83.32M82.56M
自由现金流 -32.52M-46.15M-70.30M-141.86M-133.41M-165.46M-137.79M-4.41M
已派股息 ----------------
股票回购/发行 51.90M55.83M111.04M100.87M0213.18M00
期末现金余额 29.05M47.11M107.77M187.25M84.70M220.97M138.84M160.81M

回报与效率指标

项目 2018 2019 2020 2021 2022 2023 2024 2025
净资产收益率 ---186.27-91.05-137.91-712.49-901.57-507.05--
总资产收益率 -39.66-38.07-36.64-34.64-28.03-28.31-20.51-18.30
投入资本回报率 ---69.96-51.28-45.78-37.23-34.74-23.44--
5年平均净资产收益率 -----------389.84-454.00--
息税前利润率 -25.12-34.09-45.89-56.35-41.75-35.31-22.43-12.76
自由现金流/营收 ----------------
流动比率 2.472.983.163.281.842.862.732.06
速动比率 1.451.742.272.271.041.861.451.18
资产负债率 35.2033.0516.5062.1375.9967.2778.6375.34
长期负债权益比 240.69124.6229.29441.78--684.51--4,227.51
利息保障倍数 -3.23---5.37-19.28-26.61-10.23-5.51-2.12
营收复合年增长率(3年) -11.96-1.9312.5038.4345.7149.3235.9829.62
净利润复合年增长率(3年) ----------------
自由现金流复合年增长率(3年) ----------------

营收构成 最近报告期

业务分部

Revenue from products and services100.00%

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

阿尔法科技骨科 讨论区 0 条评论

发表评论